Wednesday, March 18, 2026
HomeTagsTumor-activated biologics

tumor-activated biologics

Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Tumor-Activated ADCs

Voro Therapeutics, a biotechnology company pioneering tumor-activated biologics using its proprietary PrimeBody platform, announced a research collaboration with Daiichi Sankyo through its Daiichi Sankyo...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics